| Literature DB >> 30326828 |
Angela Kranz1,2, Andrea Steinmann1,2, Ursula Degner1, Aliye Mengus-Kaya1, Susana Matamouros1, Michael Bott1,2, Tino Polen3,4.
Abstract
BACKGROUND: Gluconobacter oxydans is a strictly aerobic Gram-negative acetic acid bacterium used industrially for oxidative biotransformations due to its exceptional type of catabolism. It incompletely oxidizes a wide variety of carbohydrates regio- and stereoselectively in the periplasm using membrane-bound dehydrogenases with accumulation of the products in the medium. As a consequence, only a small fraction of the carbon and energy source enters the cell, resulting in a low biomass yield. Additionally, central carbon metabolism is characterized by the absence of a functional glycolysis and absence of a functional tricarboxylic acid (TCA) cycle. Due to these features, G. oxydans is a highly interesting model organism. Here we analyzed global mRNA decay in G. oxydans to describe its characteristic features and to identify short-lived mRNAs representing potential bottlenecks in the metabolism for further growth improvement by metabolic engineering.Entities:
Keywords: 23S rRNA fragmentation; ATP synthase; Gluconobacter oxydans; Intervening sequence; Ribosome; Tricarboxylic acid cycle; mRNA decay
Mesh:
Substances:
Year: 2018 PMID: 30326828 PMCID: PMC6191907 DOI: 10.1186/s12864-018-5111-1
Source DB: PubMed Journal: BMC Genomics ISSN: 1471-2164 Impact factor: 3.969
Fig. 1Overview of global mRNA decay analysis. a Growth of G. oxydans 621H in the presence of different concentrations of rifampicin as well as the controls methanol and water. The addition of rifampicin or a control is indicated by the arrow. b Formaldehyde agarose gel (1.8%) analysis to inspect the quality of total RNA isolated from G. oxydans cells before and 2, 5, 10, and 15 min after addition of 150 μg/mL of rifampicin. Aliquots of 1 μg of total RNA were loaded. Bands corresponding to the 23S rRNAs (2709 to 2711 nt) and the 16S rRNAs (1478 nt) are indicated as well as the sizes of the RNA fragments present in the RiboRuler Low Range RNA Ladder (M). w/o Rif, without rifampicin. c Schema of the experimental design. RNA isolated at the given time points were mixed with Spike-In RNA mix A or B and used for cDNA synthesis and Cy3 or Cy5 labeling. cDNA synthesized from RNA isolated from cells before addition of rifampicin (t0) and 2, 5, 10, and 15 min after addition of 150 μg/mL rifampicin were pairwise mixed and hybridized on Agilent 4-plex arrays. mRNA half-lives were calculated based on three biological replicates including dye-swap labeling. d Histogram showing the distribution of calculated mRNA half-lives of 2500 genes from G. oxydans where R2 was > 0.7 when using all four or the first three sampling times
Functional categories or subcategories comprising 1582 assigned protein-coding ORFs with mean mRNA half-lives based on data from 1526 (96%) transcripts (Additional file 1: Table S1)
| functional category / pathway a) | number of genes | |||
|---|---|---|---|---|
| assigned a) | with a calculated mRNA half-life | proportion (%) | half-life b) (min) | |
| ATP-proton motive force interconversion | 18 | 18 | 100 | 4.0** |
| RNA metabolism | 23 | 23 | 100 | 4.4* |
| Cell division | 26 | 26 | 100 | 4.6 |
| DNA degradation | 9 | 9 | 100 | 4.7 |
| Transcription | 13 | 10 | 77 | 4.7 |
| Mono/dioxygenase | 10 | 10 | 100 | 4.7 |
| Fatty acid and phospholipid metabolism | 36 | 36 | 100 | 4.7 |
| Antibiotics resistance | 12 | 12 | 100 | 4.7 |
| tRNA metabolism | 13 | 13 | 100 | 4.7 |
| Nucleotide metabolism | 59 | 58 | 98 | 4.8 |
| Signal transduction | 30 | 29 | 97 | 4.8 |
| Cell envelope | 134 | 131 | 98 | 4.9 |
| Amino acid metabolism | 120 | 117 | 98 | 5.0 |
| Central intermediary metabolism | 33 | 31 | 94 | 5.0 |
| Degradation of proteins and peptides | 51 | 48 | 94 | 5.0 |
| Ribosome assembly | 67 | 52 | 78 | 5.0 |
| DNA replication | 26 | 26 | 100 | 5.1 |
| Pyruvate metabolism | 12 | 11 | 92 | 5.1 |
| Regulatory functions | 99 | 94 | 95 | 5.1 |
| DNA repair | 34 | 34 | 100 | 5.2 |
| Transport | 232 | 227 | 98 | 5.2 |
| Aminoacyl-tRNA biosynthesis | 33 | 33 | 100 | 5.3 |
| Pentose phosphate pathway | 13 | 13 | 100 | 5.3 |
| Biosynthesis of cofactors | 85 | 84 | 99 | 5.4 |
| Translation factors | 20 | 20 | 100 | 5.4 |
| DNA recombination | 18 | 17 | 94 | 5.5 |
| Electron transport | 53 | 53 | 100 | 5.5 |
| Unknown function | 41 | 40 | 98 | 5.5 |
| Detoxification | 30 | 27 | 90 | 5.6 |
| Tricarboxylic acid cycle | 9 | 9 | 100 | 5.6 |
| Uncharacterized oxidoreductase | 66 | 63 | 96 | 5.7 |
| Adaptations to atypical conditions | 19 | 19 | 100 | 6.1 |
| Protein folding and stabilization | 28 | 28 | 100 | 6.3 |
| Sugar and alcohol degradation | 25 | 24 | 96 | 6.3 |
| Biosynthesis and degradation of polymers | 11 | 10 | 91 | 6.4 |
| Glycolysis / Gluconeogenesis | 17 | 16 | 94 | 6.5 |
| Cell motility | 41 | 39 | 95 | 6.6 |
| Entner-Doudoroff pathway | 2 | 2 | 100 | 6.7 |
| Ion homeostasis | 6 | 6 | 100 | 6.7 |
| DNA restriction and modification | 8 | 8 | 100 | 7.0 |
a)Functional categories and number of genes are based on assigned gene product functions [11]
b)Functional categories with significantly shorter or longer mean half-lives than the overall mean half-life (5.7 min) are highlighted by ** (p < 0.001) or * (p < 0.05)
Fig. 2Distribution of mRNA half-lives () with mean value indicator () based on the functional categories or subcategories and number of genes given in Table 1
Fig. 3mRNA half-lives versus FPKM expression values and ORF lengths. a Linear regression analysis showed a statistically significant slightly negative correlation (R = −0.24) between the abundance of transcripts and their half-lives. Plots are related to the half-life data obtained for 2500 transcripts () with R2 > 0.7 based on the 4 or 3 sampling times as described. Transcripts of the molecular chaperones GroES (GOX1901) and GroEL (GOX1901) exhibited high expression values as well as long half-lives (). The operons of the F1Fo-type ATP synthase encoded by atpBEFF’ (GOX1110–13) and atpHAGDC (GOX1310–14) () belong to the operons/genes with the shortest mRNA half-lives in G. oxydans. In comparison, the transcripts of the second F1Fo-type ATP synthase encoded by GOX2167–75 () exhibited almost 2-fold longer half-lives and approximately 80-fold lower expression values. Among the genes of the incomplete TCA cycle () the transcript of aconitase of (acn, GOX1335) was the most stable, while the transcripts of malate:quinone oxidoreductase (mqo, GOX2070), dihydrolipoamide succinyl transferase (E2) of 2-oxoglutarate dehydrogenase (odhB, GOX1073), and dihydrolipoamide dehydrogenase (lpd, GOX2292) exhibited the shortest mRNA half-lives. FPKM values were obtained with cells grown on mannitol. b The mRNA half-lives and ORF lengths of 2500 transcripts () did not correlate (R = − 0.06)
Top 20 operons exhibiting the shortest mRNA half-lives in G. oxydans and their assigned gene expression values FPKM. The arrow lines indicate operon genes and genomic orientation.
| locus tag / operon | annotation | operon half-life Ø (min) | half-life (min) | FPKM | |
|---|---|---|---|---|---|
| | | GOX1310a | F1Fo ATP synthase subunit delta | 3.1 | 3.7 | 6320 |
| | | GOX1311a | F1Fo ATP synthase subunit alpha | 3.0 | 1780 | |
| | | GOX1312a | F1Fo ATP synthase subunit gamma | 3.1 | 1232 | |
| | | GOX1313a | F1Fo ATP synthase subunit beta | 2.9 | 1651 | |
| ↓ | GOX1314a | F1Fo ATP synthase epsilon chain | 3.1 | 6950 | |
| | | GOX1737 | rod shape-determining protein MreB | 2.8 | 2.4 | 908 |
| | | GOX1738 | rod shape-determining protein MreC | 2.8 | 383 | |
| ↓ | GOX1739 | hypothetical protein | 3.0 | 93 | |
| ↑ | GOX1110a | F1Fo ATP synthase subunit b’ | 2.8 | 2.9 | 937 |
| | | GOX1111a | F1Fo ATP synthase subunit b | 2.9 | 1600 | |
| | | GOX1112a | F1Fo ATP synthase C chain | 2.9 | 1743 | |
| | | GOX1113a | F1Fo ATP synthase subunit a | 2.4 | 1911 | |
| | | GOX0149 | cell division protein MraZ | 2.8 | 3.0 | 2124 |
| | | GOX0150 | SAM-dependent methytransferase | 2.8 | 528 | |
| ↓ | GOX0151 | hypothetical protein | 2.6 | 255 | |
| ↓ | GOX1427 | FAD-dependent thymidylate synthase | 2.7 | 2.7 | 1121 |
| ↑ | GOX0476 | putative oxidoreductase | 2.7 | 2.9 | 658 |
| | | GOX0477 | hypothetical protein | 2.5 | 847 | |
| | | GOX0478 | putative oxidoreductase | 2.8 | 1202 | |
| ↑ | GOX1596 | hypothetical protein | 2.7 | 2.7 | 119 |
| ↓ | GOX2462 | transcriptional regulator | 2.7 | 2.7 | 4866 |
| ↑ | GOX0607 | D-alanyl-D-alanine carboxypeptidase | 2.7 | 2.7 | 1540 |
| | | GOX1430 | serine protease | 2.7 | 2.8 | 170 |
| ↓ | GOX1431 | hypothetical protein | 2.6 | 336 | |
| | | GOX0024 | undecaprenyl pyrophosphate phosphatase | 2.6 | 2.8 | 198 |
| ↓ | GOX0025 | amino acid permease | 2.5 | 142 | |
| ↑ | GOX2207 | methylenetetrahydrofolate reductase | 2.6 | 2.6 | 547 |
| ↓ | GOX0649 | sugar-proton symporter | 2.6 | 2.6 | 364 |
| ↓ | GOX2378 | short chain alcohol dehydrogenase | 2.6 | 2.6 | 301 |
| ↑ | GOX1151 | hypothetical protein | 2.5 | 2.5 | 2854 |
| ↑ | GOX1696 | hypothetical protein | 2.5 | 2.5 | 35 |
| ↑ | GOX2067 | manganese transport protein MntH | 2.5 | 2.5 | 526 |
| ↓ | GOX0942 | hypothetical protein | 2.5 | 2.5 | 178 |
| ↑ | GOX1652 | heme exporter protein C | 2.4 | 2.4 | 323 |
| ↑ | GOX0666 | outer membrane receptor for ferric iron uptake | 2.4 | 2.4 | 222 |
| ↑ | GOX1426 | hypothetical protein | 2.4 | 2.4 | 577 |
a) For the F1Fo ATP synthase encoded by two operons the data of the operon GOX1310–14, which was close to the top 20, were also included
mRNA half-lives and expression values (FPKM) of genes encoding annotated membrane-bound dehydrogenases. The arrow lines indicate operon genes and genomic orientation.
| locus tag / operon | annotation | half-life (min) | FPKM | |
|---|---|---|---|---|
| ↓ | GOX0265 | membrane-bound glucose dehydrogenase (PQQ) | 4.4 | 146 |
| ↑ | GOX0516 | PQQ-dependent dehydrogenase 4 | 8.3 | 22 |
| | | GOX0585 | cytochrome c subunit of aldehyde dehydrogenase | 3.7 | 32 |
| | | GOX0586 | membrane-bound aldehyde dehydrogenase, small subunit | 3.7 | 38 |
| ↓ | GOX0587 | membrane-bound aldehyde dehydrogenase, large subunit | 9.0 | 31 |
| ↑ | GOX0854 | polyol dehydrogenase subunit SldA | 4.2 | 2147 |
| | | GOX0855 | polyol dehydrogenase subunit SldB | 4.6 | 5992 |
| ↑ | GOX1067 | alcohol dehydrogenase cytochrome c subunit precursor | 4.0 | 1807 |
| | | GOX1068 | alcohol dehydrogenase large subunit | 3.4 | 1706 |
| ↑ | GOX1230 | gluconate 2-dehydrogenase, cytochrome c subunit | 9.0 | 208 |
| | | GOX1231 | gluconate 2-dehydrogenase alpha chain | 8.5 | 791 |
| | | GOX1232 | gluconate 2-dehydrogenase gamma chain | 7.8 | 684 |
| ↓ | GOX1253 | D-lactate dehydrogenase | 5.0 | 159 |
| ↑ | GOX1441 | PQQ-dependent dehydrogenase 3 | 4.7 | 31 |
| ↑ | GOX1857 | PQQ-containing dehydrogenase 1 | 7.1 | 122 |
| | | GOX1968 | hypothetical protein | 3.6 | 496 |
| | | GOX1969 | alcohol dehydrogenase large subunit | 3.5 | 540 |
| ↓ | GOX1970 | GTP-binding protein EngA | 4.3 | 408 |
| ↑ | GOX2094 | sorbitol dehydrogenase cytochrome c subunit | 5.8 | 10 |
| | | GOX2095 | sorbitol dehydrogenase large subunit | 5.3 | 13 |
| | | GOX2096 | sorbitol dehydrogenase large subunit | 4.1 | 51 |
| | | GOX2097 | sorbitol dehydrogenase small subunit | 3.5 | 74 |
Fig. 4mRNA half-lives and FPKM expression values for genes of the central carbon metabolism. Upper boxes representing a Log2 expression value were colored according to the black-yellow gradient ranging from 4 to 13 (Additional file 1: Table S2). Lower boxes representing a half-life were colored according to the red-green gradient ranging from 3 to 13 min (Additional file 1: Table S1). Genes/Enzymes: aceEα, pyruvate dehydrogenase E1 component alpha subunit (GOX2289); aceEß, pyruvate dehydrogenase E1 component beta subunit (GOX2290); aceF, dihydrolipoamide acetyltransferase component of pyruvate dehydrogenase (GOX2291); acn, aconitate hydratase (GOX1335); ald, aldehyde dehydrogenase (GOX2018); eda, KDPG aldolase (GOX0430); edd, phosphogluconate dehydratase (GOX0431); eno, enolase (GOX2279); fba, fructose-bisphosphate aldolase (GOX0780); fbp, fructose 1,6-bisphosphatase (GOX1516); frk, fructokinase (GOX0284); fumC, fumarate hydratase (GOX1643); gap, glyceraldehyde 3-phosphate dehydrogenase (GOX0508); gdhM, membrane-bound glucose dehydrogenase (GOX0265); gdhS, soluble glucose dehydrogenase (GOX2015); glk, glucokinase (GOX2419); (glk), putative glucokinase (GOX1182); gltA, citrate synthase (GOX1999); gnd, 6-phosphogluconate dehydrogenase (GOX1705); gnk, gluconokinase (GOX1709); gno, gluconate 5-dehydrogenase (GOX2187); gpm phosphoglyceromutase (GOX0330); icd, isocitrate dehydrogenase (GOX1336); lpd, dihydrolipoamide dehydrogenase (GOX2292); mqo, malate:quinone oxidoreductase (GOX2070); odhA, 2-oxoglutarate dehydrogenase E1 component (GOX0882); odhB, dihydrolipoamide succinyltransferase E2 component of 2-oxoglutarate dehydrogenase complex (GOX1073); pdc, pyruvate decarboxylase (GOX1081); pgk, phosphoglycerate kinase (GOX0507); pgl, 6-phosphogluconolactonase (GOX1707); ppc, phosphoenolpyruvate carboxylase (GOX0102); pyk, pyruvate kinase (GOX2250); rpe, ribulosephosphate 3-epimerase (GOX1352); rpi, ribose 5-phosphate isomerase (GOX1708); sldA, polyol dehydrogenase subunit SldA (GOX0854); sldB, polyol dehydrogenase subunit SldB (GOX0855); tal/pgi, bifunctional transaldolase (GOX1704); tkt, transketolase (GOX1703); tpi, triosephosphate isomerase (GOX2217); zwf, glucose-6-phosphate 1-dehydrogenase (GOX0145). Metabolites: 1,3-BPG, 1,3-bisphosphoglycerate; 2-KFRU, 2-ketofructose; 2-OG, 2-oxoglutarate; 2PGA, 2-phosphogylcerate; 3PGA, 3-phosphoglycerate; 5-KGLCNT, 5-ketogluconate; 6PG, 6-phosphogluconate; 6PGL, 6-phosphogluconolactone; ACD, acetaldehyde; ACE, acetate; AcCoA, acetyl coenzyme A; CIT, citrate; CoA, coenzyme A; DHAP, dihydroxyacetone phosphate; E4P, erythrose 4-phosphate; F6P, fructose 6-phosphate; FBP, fructose 1,6-bisphosphate; FRU, fructose; FUM, fumarate; G-1,5-LC, glucono-1,5-lactone; G6P, glucose 6-phosphate; GAP, glyceraldehyde 3-phosphate; GLC, glucose; GLCNT, gluconate; ICIT, isocitrate; KDPG, 2-keto-3-deoxy-6-phosphogluconate; MAL, malate; MAN, mannitol; OAA, oxaloacetate; PEP, phosphoenolpyruvate; PYR, pyruvate; R5P, ribose 5-phosphate; RU5P, ribulose 5-phosphate; S7P, sedoheptulose 7-phosphate; SucCoA, succinyl coenzyme A; X5P, xylulose 5-phosphate
Fig. 5Graphical representation of the 23S rRNA (a, b) and 16S rRNA (c) mapping coverage. The mapping is based on the Illumina reads obtained with RNA samples isolated from enriched ribosomes (peak P3) from cells in the exponential growth phase. The y axes are zoomed to a maximum of 150 to better illustrate the very low coverage regions (< 5%) indicated by the arrows. a Mapping coverage of the 23S rRNA locus GOX1319 (2711 nt). The same coverage pattern was obtained for the 23S rRNA loci GOX0221 and GOX1467 (2710 nt). b Mapping coverage of the 23S rRNA locus GOX1159 (2709 nt) which indicates an additional fragmentation site. c Mapping coverage obtained for the 16S rRNA locus GOX1156. The same coverage pattern was observed for the other 16S rRNA loci GOX0224, GOX1316, and GOX1464